Intuitive Surgical, Inc. ISRG
405.18
5.66
1.42%
as of 25 Sep
- Market cap
- $140.7B
- P/E
- 45.8×
Follow ISRG
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Intuitive Surgical, Inc. (ISRG) P/B ratio
As of 25 September 2026, Intuitive Surgical, Inc. (ISRG) trades at a P/B ratio of 7.8×. Over the past ten years it has ranged from 4.1× (October 2015) to 13.1× (January 2025); the current reading is higher than 33% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 11.3× | 0.44% |
| FY2024 | 11.2× | 29.27% |
| FY2023 | 8.7× | 2.05% |
| FY2022 | 8.5× | (20.58%) |
| FY2021 | 10.7× | 9.12% |
| FY2020 | 9.8× | 19.15% |
| FY2019 | 8.2× | 1.13% |
| FY2018 | 8.1× | (7.13%) |
| FY2017 | 8.8× | 106.10% |
| FY2016 | 4.3× | (9.30%) |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 7.7× | (17.22%) |
| Mar 2026 | 9.3× | (17.48%) |
| Dec 2025 | 11.3× | 20.39% |
| Sep 2025 | 9.4× | (13.76%) |
| 42 more quarters | Free account |
Against its own ten years
Low 4.1×
High 13.1×
Ten-year median
8.6×
Current reading's percentile
33
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| ALC Alcon compare | 1.5× |
| MDLN Medline Inc. compare | 1.6× |
| BAX Baxter International Inc. compare | 2.0× |
| BDX Becton, Dickinson and Company compare | 2.1× |
| SOLV Solventum Corporation compare | 3.2× |
| RMD ResMed Inc. compare | 4.9× |
| RGEN Repligen Corporation compare | 5.1× |
| ISRG Intuitive Surgical, Inc. | 7.8× |
| WST West Pharmaceutical Services, Inc. compare | 8.8× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ISRG
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement